HOUSTON--(BUSINESS WIRE)--Bio-Path Holdings, Inc. (OTCBB: BPTH) (“Bio-Path”), a biotechnology company developing a liposomal delivery technology for nucleic acid cancer drugs, today announced that Peter Nielsen, President and Chief Executive Officer, will present a company overview at the 10th Annual BIO Investor Forum Conference in San Francisco on Wednesday, October 26, 2011 at 3:00 p.m. Pacific Time (6:00 p.m. Eastern Time).
